Related Experiment Video
Updated: May 15, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Dynamical modeling of drug effect using hybrid systems.
Xiangfang Li1, Lijun Qian, Edward R Dougherty
1Department of Electrical and Computer Engineering, Texas A&M University, College Station, TX 77843, USA. xiangfangli@ieee.org.
EURASIP Journal on Bioinformatics & Systems Biology
|December 28, 2012
Summary
This study introduces a novel hybrid systems model for drug discovery, enhancing efficiency by analyzing gene regulatory networks under drug perturbations. The model aids in understanding system dynamics for improved therapeutic interventions.
Area of Science:
- Systems Biology
- Pharmacology
- Computational Biology
Background:
- Drug discovery is inefficient, costly, and time-consuming with high failure rates.
- A systematic approach integrating innovative methods is crucial for effective drug development.
Purpose of the Study:
- To provide mathematical analysis and dynamical modeling of drug effects within gene regulatory networks.
- To develop a hybrid systems model for studying network dynamics under drug perturbations.
- To offer insights for optimizing therapeutic interventions.
Main Methods:
- Developed a hybrid systems model combining discrete and continuous dynamics.
- Analyzed drug effects on gene regulatory network dynamics.
- Incorporated drug pharmacokinetics and pharmacodynamics into the model.
- Considered realistic periodic drug intake scenarios.
Main Results:
- The hybrid systems model effectively simulates drug perturbations on gene regulatory networks.
- The model allows for the analysis of system changes in response to drug interventions.
- Simulation results corroborate the analytical findings.
Conclusions:
- The proposed hybrid systems model offers a systematic approach to understanding drug effects in complex biological systems.
- This modeling framework can guide the development of more efficient and effective therapeutic strategies.
- The integration of pharmacokinetic and pharmacodynamic data enhances the model's predictive power for drug development.
Related Concept Videos
01:14Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...
01:29Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
01:20Pharmacokinetic Models: Overview
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.